COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 943: Articles 9421-9430  | Next

Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems
McConeghy, K. W., Bardenheier, B., Huang, A. W., White, E. M., Feifer, R. A., Blackman, C., Santostefano, C. M., Lee, Y., DeVone, F., Halladay, C. W., Rudolph, J. L., Zullo, A. R., Mor, V., Gravenstein, S.
10.1101/2022.01.25.22269843 — Posted: 2022-01-28
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines
Carreno, J. M., Raskin, A., Singh, G., Tcheou, J., Kawabata, H., Gleason, C., Srivastava, K., Vigdorovich, V., Dambrauskas, N., Gupta, S. L., Gonzalez, I., Martinez, J. L., Slamanig, S., Sather, D. N., Raghunandan, R., Wirachwong, P., Muangnoicharoen, S., Pitisuttithum, P., Wrammert, J., Suthar, M. S., Sun, W., Palese, P., Garcia-Sastre, A., Simon, V., Krammer, F.
10.1101/2022.01.25.22269808 — Posted: 2022-01-28
How dangerous is omicron and how effective are vaccinations?
Nesteruk, I., Rodionov, O.
10.1101/2022.01.27.22269909 — Posted: 2022-01-28
Cardiovascular, respiratory and functional effects of tele-supervised home-based exercise training in individuals recovering from COVID-19 hospitalization: A randomized clinical trial
Amaral, V. T. d., Viana, A. A., Heubel, A. D., Linares, S. N., Martinelli, B., Witzler, P. H. C., Oliveira, G. Y. O. d., Zanini, G. d. S., Silva, A. B., Mendes, R. G., Ciolac, E. G.
10.1101/2022.01.24.22269745 — Posted: 2022-01-28
COVID-19 vaccine attitude and its predictors among people living with chronic health conditions in Ibadan, Nigeria
Ojewale, L. Y., Afolabi, R. F., Ogunniyi, A.
10.1101/2022.01.27.22269947 — Posted: 2022-01-28
Open science policies of medical and health sciences journals before and during the COVID-19 pandemic: a repeat cross-sectional study
Gardener, A. D., Hicks, E. J., Jacklin, C., Tan, G., Cashin, A. G., Lee, H., Nunan, D., Toomey, E. C., Richards, G. C.
10.1101/2022.01.26.22269868 — Posted: 2022-01-28
EPIDEMIOLOGICAL CHARACTERISTICS AND SEVERITY OF OMICRON VARIANT CASES IN THE APHP CRITICAL CARE UNITS; THE APHP REALITY RESEARCH GROUP
Vieillard-Baron, A., APHP Reality research group
10.1101/2022.01.25.22269839 — Posted: 2022-01-28
Immunogenicity of COVID-19 mRNA Vaccines in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Helfgott, D. C., Racine-Brzostek, S., Short, K. J., Zhao, Z., Christos, P., Nino, I., Niu, T., Contreras, J., Ritchie, E. K., Desai, P., Samuel, M., Roboz, G. J.
10.1101/2022.01.26.22269932 — Posted: 2022-01-28
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads
Fall, A., Eldesouki, R., Sachithanandham, J., Morris, C. P., Norton, J., Gaston, D., Forman, M., Abdullah, O., Gallagher, N., Li, M., Swanson, N. J., Pekosz, A., Klein, E., Mostafa, H.
10.1101/2022.01.26.22269927 — Posted: 2022-01-28
Humoral immune response of patients infected by earlier lineages of SARS-CoV-2 neutralizes wild types of the most prevalent variants in Brazil
Pauvolid-Correa, A., Costa Caetano, B., Machado, A. B., Araujo Ferreira, M., Valente, N., Keren, T., Geraldo, K., Motta, F., Goncalves Veloso dos Santos, V., Grinsztejn, B., Mendonca Siqueira, M., Resende, P. C.
10.1101/2022.01.24.22269379 — Posted: 2022-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).